Table of Contents

Articles

• You have access

  Glucuronidation of Amines and Other Xenobiotics Catalyzed by Expressed Human UDP-Glucuronosyltransferase 1A3

  Mitchell D. Green, Christopher D. King, Behnaz Mojarrabi, Peter I. Mackenzie and Thomas R. Tephly

  Drug Metabolism and Disposition June 1998, 26 (6) 507-512;
• You have access

  The In Vitro Metabolism of Penclomedine in Mouse, Rat, and Human Systems

  Neil R. Hartman, K. U. Leo, T. G. Brewer and J. M. Strong

  Drug Metabolism and Disposition June 1998, 26 (6) 513-519;
• You have access

  In Vitro and In Vivo Evaluations of Intestinal Barriers for the Zwitterion L-767,679 and Its Carboxyl Ester Prodrug L-775,318

  Thomayant Prueksaritanont, Polly DeLuna, Lynn M. Gorham, Bennett Ma, Dosinda Cohn, Jianmei Pang, Xin Xu, Kwan Leung and Jiunn H. Lin

  Drug Metabolism and Disposition June 1998, 26 (6) 520-527;
• You have access

  Biotransformation of Tolterodine, a New Muscarinic Receptor Antagonist, in Mice, Rats, and Dogs

  Stig H. G. Andersson, Anders Lindgren and Hans Postlind

  Drug Metabolism and Disposition June 1998, 26 (6) 528-535;
• You have access

  In Vitro Characterization of Cytochrome P450 2D6 Inhibition by Classic Histamine H₁ Receptor Antagonists

  Bettina A. Hamelin, Asmàa Bouayad, Benoît Drolet, Anne Gravel and Jacques Turgeon

  Drug Metabolism and Disposition June 1998, 26 (6) 536-539;
• You have access

  Biotransformation of the Anthraquinones Emodin and Chrysophanol by Cytochrome P450 Enzymes

  Stefan O. Mueller, Helga Stopper and Wolfgang Dekant

  Drug Metabolism and Disposition June 1998, 26 (6) 540-546;
• You have access

  Thiol Agents Separate Nitric Oxide Formation from Vasodilation Induced by Glyceryl Trinitrate

  Mark F. Kearney, James F. Brien, Gerald S. Marks, Hua Lei and Kanji Nakatsu

  Drug Metabolism and Disposition June 1998, 26 (6) 547-551;
• You have access

  Metabolism of the Human Immunodeficiency Virus Protease Inhibitors Indinavir and Ritonavir by Human Intestinal Microsomes and Expressed Cytochrome P4503A4/3A5: Mechanism-Based Inactivation of Cytochrome P4503A by Ritonavir

  Tatiana Koudriakova, Eugenia Iatsimirskaia, Ilya Utkin, Eric Gangl, Paul Vouros, Elena Storozhuk, Daniela Orza, Julia Marinina and Nicholas Gerber

  Drug Metabolism and Disposition June 1998, 26 (6) 552-561;
• You have access

  Analysis of Metabolite Formation Pharmacokinetics after Intravenous and Oral Administration of the Parent Drug Using Inverse Laplace Transformation

  Michael Weiss

  Drug Metabolism and Disposition June 1998, 26 (6) 562-565;
• You have access

  N-Dealkylation and Hydroxylation of Ebastine by Human Liver Cytochrome P450

  Takanori Hashizume, Masashi Mise, Yoshiaki Terauchi, Luan O, Toshihiko Fujii, Hisashi Miyazaki and Tadanobu Inaba

  Drug Metabolism and Disposition June 1998, 26 (6) 566-571;
• You have access

  Trazodone Is Metabolized tom-Chlorophenylpiperazine by CYP3A4 from Human Sources

  Susan Rotzinger, Jian Fang and Glen B. Baker

  Drug Metabolism and Disposition June 1998, 26 (6) 572-575;
• You have access

  Pharmacokinetics of Meloxicam in Animals and The Relevance to Humans

  Ulrich Busch, Jochen Schmid, Günther Heinzel, Helmut Schmaus, Jürgen Baierl, Claudia Huber and Willy Roth

  Drug Metabolism and Disposition June 1998, 26 (6) 576-584;
• You have access

  Physiologically Based Pharmacokinetics Model of Primidone and Its Metabolites Phenobarbital and Phenylethylmalonamide in Humans, Rats, and Mice

  Hisham A. El-Masri and Christopher J. Portier

  Drug Metabolism and Disposition June 1998, 26 (6) 585-594;
• You have access

  Effect of Hypoalbuminemia on the Disposition of Theophylline

  Hironori Nakura, Tomonori Tateishi, Minoru Watanabe, Masako Asoh, Masami Tanaka, Toshio Kumai and Shinichi Kobayashi

  Drug Metabolism and Disposition June 1998, 26 (6) 595-597;
• You have access

  Tissue-Specific Expression of Rat Sulfotransferase Messenger RNAs

  Robert T. Dunn and Curtis D. Klaassen

  Drug Metabolism and Disposition June 1998, 26 (6) 598-604;